Cargando…
Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues
The coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic as declared by World Health Organization (WHO). In the absence of an effective treatment, different drugs with unknown effectiveness, including antimal...
Autores principales: | Wong, Andy On-Tik, Gurung, Bimal, Wong, Wing Sum, Mak, Suet Yee, Tse, Wan Wai, Li, Chloe M., Lieu, Deborah K., Costa, Kevin D., Li, Ronald A., Hajjar, Roger J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765761/ https://www.ncbi.nlm.nih.gov/pubmed/33373642 http://dx.doi.org/10.1016/j.yjmcc.2020.12.014 |
Ejemplares similares
-
Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues
por: Wong, Andy O.-T., et al.
Publicado: (2021) -
Correlation between frataxin expression and contractility revealed by in vitro Friedreich’s ataxia cardiac tissue models engineered from human pluripotent stem cells
por: Wong, Andy On-Tik, et al.
Publicado: (2019) -
Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases
por: Zhu, Xiaojia, et al.
Publicado: (2022) -
Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
por: Wu, Qin, et al.
Publicado: (2023) -
Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)